Orakl Oncology
Leveraging patient tumor avatars to transform drug development in oncology.
Cancer complexity leads to a 96% failure rate of drug candidates in clinical trials and a shortage of new treatments. Orakl Oncology’s ambition is to finally address the heterogeneity of cancer and patient specificities as early as possible in drug development.
By creating a collection of avatars of patients’ tumors, they predict how each patient will respond to future drugs, combining best-in-class biology with deep clinical data and machine learning to efficiently discover and optimize new treatments for the right patients.
hi.health
Convenient and safe access to private health insurance billing.
IOMED
Better ICD-10 coding and big data insights for hospitals.
Juli
Improving life for people with chronic conditions.
MiLaboratories
The leader in immunome data analysis software with flagship product MiXCR.
Molecule
Connecting life science research to funding.
Mpiriq
MPIRIQ links everyday clinical data with medical research to turn routine patient care into insights that accelerate new therapies.
NeuroHarmonics
Building the future of non-invasive neuromodulation using focused ultrasound to modulate deep brain circuits safely.
Nilo Health
The mental well-being support for your entire workforce.
